ZYME Earnings & Financial Statements
Zymeworks Inc.
$25.75
+$0.98(+3.96%)
55
Overall
60
Value
50
Tech
55
Quality
Market Cap
$1.76B
Volume
735.64K
52W Range
$16.00 - $31.34
Target Price
$40.93
ZYME earnings and financial statements: Zymeworks Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
ZYME Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $105.97M | $76.30M | $76.01M | $412.48M | $26.68M |
| Operating income | -$92.55M | -$137.11M | -$138.05M | $130.53M | -$215.63M |
| EBITDA | -$82.00M | -$125.36M | -$121.64M | $147.24M | -$206.09M |
| Net income | -$81.13M | -$122.69M | -$118.67M | $124.34M | -$211.84M |
| EPS (diluted) | $-1.08 | $-1.62 | $-1.72 | $1.90 | $-4.61 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $346.53M | $463.09M | $580.88M | $648.73M | $389.13M |
| Total liabilities | $78.03M | $124.32M | $116.07M | $155.77M | $140.04M |
| Shareholders’ equity | $268.50M | $338.77M | $464.81M | $492.96M | $249.09M |
| Cash and equivalents | $41.16M | $66.10M | $157.56M | $400.91M | $201.87M |
| Long-term debt | $14.80M | $15.74M | $22.37M | $24.67M | $30.92M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$33.01M | -$110.06M | -$118.30M | $144.11M | -$192.45M |
| Capital expenditure | -$2.35M | -$3.07M | -$4.08M | -$13.13M | -$13.29M |
| Free cash flow | -$35.36M | -$113.12M | -$122.38M | $130.98M | -$205.74M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ZYME | $25.75 | +4.0% | 735.64K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |